Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in nonluminal breast cancer: a single-arm phase II trial

被引：0
|
作者：
Liu, Deyue
Zhu, Li
Wu, Jiayi
Wang, Wei
Ding, Shuning
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)
    Sharma, Priyanka
    Kimler, Bruce F.
    O'Dea, Anne
    Nye, Lauren
    Wang, Yen Y.
    Yoder, Rachel
    Staley, Joshua M.
    Prochaska, Lindsey
    Wagner, Jamie
    Amin, Amanda L.
    Larson, Kelsey
    Balanoff, Christa
    Elia, Manana
    Crane, Gregory
    Madhusudhana, Sheshadri
    Hoffmann, Marc
    Sheehan, Maureen
    Rodriguez, Roberto
    Finke, Karissa
    Shah, Rajvi
    Satelli, Deepti
    Shrestha, Anuj
    Beck, Larry
    McKittrick, Richard
    Pluenneke, Robert
    Raja, Vinay
    Beeki, Venkatadri
    Corum, Larry
    Heldstab, Jaimie
    LaFaver, Stephanie
    Prager, Micki
    Phadnis, Milind
    Mudaranthakam, Dinesh Pal
    Jensen, Roy A.
    Godwin, Andrew K.
    Salgado, Roberto
    Mehta, Kathan
    Khan, Qamar
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 975 - 982
  • [32] Tislelizumab combined with nab-paclitaxel, adriamycin and cyclophosphamide chemotherapy in neoadjuvant treatment in triple-negative breast cancer: A prospective, single-arm, open-label phase II study
    Zhang, G.
    He, Y.
    Luo, D.
    Zhang, X.
    Gao, B.
    Jiang, Y.
    Zhao, J.
    Guo, L.
    Xu, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1414 - S1414
  • [33] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Study of neoadjuvant therapy with FEC followed by weekly nab-paclitaxel for breast cancer
    Nakagawa, S.
    Toh, U.
    Iwakuma, N.
    Mishima, M.
    Takahashi, R.
    Furukawa, M.
    Yamaguchi, M.
    Tanaka, M.
    Ogo, E.
    Akagi, Y.
    BREAST, 2015, 24 : S90 - S90
  • [35] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Ajjai Alva
    Stephanie Daignault
    David C. Smith
    Maha Hussain
    Investigational New Drugs, 2014, 32 : 188 - 194
  • [36] Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426
    Naoki, K.
    Ichikawa, Y.
    Bessho, A.
    Hosokawa, S.
    Shimokawa, T.
    Yomota, M.
    Hosomi, Y.
    Otani, S.
    Nakahara, Y.
    Iwasawa, S.
    Tokito, T.
    Seki, N.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S361 - S361
  • [37] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Alva, Ajjai
    Daignault, Stephanie
    Smith, David C.
    Hussain, Maha
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 188 - 194
  • [38] Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Eguchi, Susumu
    Inomata, Masafumi
    Nishihara, Kazuyoshi
    Shinchi, Hiroyuki
    Okuda, Koji
    Baba, Hideo
    Nagano, Hiroaki
    Ueki, Toshiharu
    Noshiro, Hirokazu
    Nakamura, Masafumi
    INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS, 2021, 25 (01): : 55 - 60
  • [39] Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial
    Kin, Takanori
    Ohtani, Shoichiro
    Maeda, Reina
    Ueno, Ayako
    Fujihara, Miwa
    Takamatsu, Yuri
    Kajiwara, Yukiko
    Ito, Mitsuya
    Kawasaki, Kensuke
    Abe, Keisuke
    Sakata, Yasuhiko
    Hiraki, Koichi
    WORLD JOURNAL OF ONCOLOGY, 2020, 11 (05) : 197 - 203
  • [40] Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
    Zhang, Yan-Feng
    Hao, An-Lin
    Hong, Yong-Gui
    Li, Xiao-Ming
    Liang, Wei-Min
    Zheng, Zhi-Xin
    Yang, Guang-Yi
    Guo, Xiao-Feng
    Wen, Yan-Yan
    Cao, Heng
    Le, Cheng
    Song, Hua-Jie
    Su, Wen-Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16015 - E16015
12345